マイクロカテーテル市場:2028年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2023年7月

マイクロカテーテル市場:タイプ (配送、診断、吸引、操作可能)、デザイン (シングル、デュアル)、用途 (心臓血管、神経血管、末梢血管、腫瘍)、エンドユーザー (病院、外来手術センター) – 2028年までの世界予測
Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) – Global Forecast to 2028

ページ数225
図表数160
種別英文調査報告書
価格

レポート目次  お問合せ・ご注文  価格・納期について

無料サンプル

The global microcatheter market is projected to reach USD 1,142 million by 2028 from USD 874 million in 2023, growing at a CAGR of 5.5% during the forecast period. The rise in advantages offered by microcatheter like Minimally Invasive, precise navigation, and targeted therapy among several others to be used are major factors anticipated to boost the market growth in the forecasting years.

マイクロカテーテル市場:2028年までの世界予測

マイクロカテーテル市場

“Steerable Microcatheters segment to register highest CAGR over the forecast period of 2023-2028”
Based on the product type, the microcatheter market is segmented into Delivery Microcatheter, Aspiration Microcatheter, Diagnostic Microcatheter, and Steerable Microcatheter. Steerable Microcatheters segment to register a highest CAGR over the forecast period of 2023-2028. Steerable microcatheters are often used in minimally invasive procedures, such as interventional radiology, neurovascular interventions, and peripheral vascular interventions. These procedures offer advantages over traditional open surgeries, including reduced patient trauma, shorter hospital stays, faster recovery times, and lower healthcare costs. The ability to navigate and steer microcatheters within the body’s intricate vasculature allows for precise and targeted treatments, further supporting the growth of steerable microcatheters.

“The Neurovascular application segment to register highest CAGR over the forecast period of 2023-2028”
Based on the application, the Microcatheters market is segmented into Cardiovascular, Neurovascular, Peripheral Vascular, Urology, Otolaryngology, and other applications. Ongoing advancements in microcatheter technology, including improvements in materials, designs, and coatings, enhance the navigational capabilities and deliverability of neurovascular microcatheters. These advancements enable physicians to reach challenging intracranial locations with greater precision and control, expanding the range of treatable lesions and improving procedural outcomes. Governments, healthcare organizations, and research institutions are investing in improving neurovascular healthcare infrastructure. This includes the availability of advanced neuro-interventional suites and the adoption of state-of-the-art neurovascular devices, including microcatheters. Such investments contribute to the growth and adoption of neurovascular microcatheters in medical facilities.

マイクロカテーテル市場 - ecosystem

“The single-lumen microcatheter segment accounted for the largest share of the microcatheter market in 2022-2028”
Based on the design, the microcatheter market is segmented into single-lumen microcatheter and Dual and Multi-lumen Microcatheter. The dual and multi-lumen microcatheter segment design segment is estimated to hold a significant market share of the microcatheter market during the forecast period.
Duel and multi-lumen microcatheters are medical devices used in various interventional procedures, particularly in the field of minimally invasive surgery. They consist of small, flexible tubes with multiple lumens (channels) that allow the simultaneous delivery of fluids, medications, and medical instruments to the target site. The drivers for using duel and multi-lumen microcatheters include:
Enhanced Procedure Efficiency: By incorporating multiple lumens within a single catheter, duel and multi-lumen microcatheters can streamline procedures by reducing the need for multiple catheter insertions. This can save time and improve overall procedural efficiency.

“Hospitals, Surgical Centers, and Specialty Clinics’ segment to register for the highest growth rate of the microcatheters market in 2022-2028”
The major end users in the microcatheters market are hospitals, surgical centers & specialty clinics, and ambulatory surgical centers. The Ambulatory surgical center’s end-user segment is estimated to hold a significant market share of the microcatheter market during the forecast period. Ambulatory surgical centers focus on providing same-day surgical procedures that minimize the need for hospitalization. Microcatheters play a vital role in enabling minimally invasive procedures, which are often preferred in ASCs due to their shorter recovery times, reduced pain, and lower cost compared to traditional open surgeries.
Technological Advances: The advancements in microcatheter technology have made these devices more versatile, reliable, and user-friendly. Improved catheter materials, enhanced flexibility, and smaller profiles allow for precise navigation through complex anatomical structures, making microcatheters suitable for a broader range of procedures performed in ASCs.

“Asia Pacific to register significant growth in the market during the forecast period.”
In 2022, the APAC region is expected to register significant growth in the market during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market for microcatheters. Several factors have contributed to this growth:
APAC countries have been experiencing rising healthcare expenditure, driven by economic growth, increasing population, and improved access to healthcare. This has led to greater investment in advanced medical technologies, including microcatheters, to support minimally invasive procedures and improve patient outcomes.
The APAC region has a large aging population, which is more prone to chronic diseases and requires specialized medical interventions. Microcatheters are extensively used in the management of cardiovascular diseases, neurovascular disorders, and other age-related conditions. The growing aging population has fueled the demand for microcatheters in APAC.
APAC countries have seen a rise in the prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurovascular disorders. Microcatheters play a crucial role in the diagnosis, treatment, and management of these conditions, leading to an increased demand for these devices in the region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level–10%, Director-level–76%, and Others–14%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

マイクロカテーテル市場 - region

Prominent players in the microcatheter market are Terumo Corporation (Tokyo, Japan), Boston Scientific Corporation (Massachusetts, US), and Cook Medical (Indiana, US), among others.

マイクロカテーテル市場 - scope

Research Coverage

This report studies the microcatheter market based on product, type, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the microcatheters market.
A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the microcatheters market. Competitive analysis of upcoming startups in the microcatheters market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall microcatheters market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

マイクロカテーテル市場 - sizeThe report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of chronic diseases, growing aging population, advancements in minimally invasive techniques), restraints (stringent regulatory requirements, high cost of microcatheters, limited availability in developing regions), opportunities (technological advancements, increasing adoption of minimally invasive procedures), and challenges (cost pressures, product complexity and variability) influencing the growth of the microcatheters market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the microcatheters market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the microcatheters market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the microcatheters market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Terumo Corporation (Tokyo, Japan), Boston Scientific Corporation (Massachusetts, US), and Cook Medical (Indiana, US), among others.


目次

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 REGIONS COVERED 26
1.3.3 INCLUSIONS AND EXCLUSIONS 27
1.3.4 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 27
1.5 RESEARCH LIMITATIONS 27
1.6 MARKET STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN: MICROCATHETERS MARKET 29
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 30
FIGURE 3 KEY DATA FROM SECONDARY SOURCES 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of primaries 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 37
FIGURE 7 MICROCATHETERS MARKET: COMPANY REVENUE ESTIMATION APPROACH 37
2.2.1.2 Approach 2: Customer-based market estimation approach 38
FIGURE 8 MICROCATHETERS MARKET: CUSTOMER-BASED MARKET SIZE ESTIMATION APPROACH 38
2.2.1.3 Approach 3: Top-down approach 39
FIGURE 9 MICROCATHETERS MARKET: TOP-DOWN APPROACH 39
2.2.1.4 Approach 4: Primary interviews 39

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 10 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET SHARE ASSESSMENT 41
2.5 STUDY ASSUMPTIONS 42
2.6 GROWTH RATE ASSUMPTIONS 42
2.7 RISK ASSESSMENT 42
TABLE 1 MICROCATHETERS MARKET: RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 43
FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 44
FIGURE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2023 VS. 2028 (USD MILLION) 45
FIGURE 14 MICROCATHETERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 45
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 46
4 PREMIUM INSIGHTS 48
4.1 MICROCATHETERS MARKET OVERVIEW 48
FIGURE 16 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS
BY GOVERNMENT TO DRIVE MARKET 48
4.2 MICROCATHETERS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 17 DELIVERY MICROCATHETERS TO DOMINATE MICROCATHETERS
MARKET IN 2028 49
4.3 MICROCATHETERS MARKET, BY REGION AND END USER, 2022 (USD MILLION) 50
FIGURE 18 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS SEGMENT DOMINATED MICROCATHETERS MARKET IN 2022 50
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 51
FIGURE 19 INDIA TO BE FASTEST GROWING COUNTRY IN GLOBAL MICROCATHETERS MARKET DURING STUDY PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 20 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Rising target patient population suffering from chronic diseases globally 53
FIGURE 21 NUMBER OF NEW CANCER CASES (GLOBAL), BY CANCER SITE (2018 VS. 2020) 53
5.2.1.2 Advancements in microcatheter technologies 54
5.2.1.3 Increase in government initiatives, healthcare funding, and health-related services 54

TABLE 2 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2022 55
5.2.1.4 Increased preference for minimally invasive surgeries over traditional open surgeries 56
5.2.2 RESTRAINTS 56
5.2.2.1 Stringent regulatory guidelines in mature markets 56
5.2.2.2 High cost of microcatheters and budget constraints in healthcare facilities 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Expansion of key players in emerging economies 57
5.2.3.2 Rising healthcare expenditure across emerging economies 57
FIGURE 22 GOVERNMENT HEALTH EXPENDITURE (% OF GDP) 58
FIGURE 23 GOVERNMENT HEALTH EXPENDITURE [AS % OF GENERAL GOVERNMENT EXPENDITURE] 58
5.2.4 CHALLENGES 59
5.2.4.1 Availability of alternative technologies for catheterization 59
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 59
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 59
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 59
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 59
5.4 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 4 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.4.1 THREAT OF NEW ENTRANTS 60
5.4.2 THREAT OF SUBSTITUTES 60
5.4.3 BARGAINING POWER OF SUPPLIERS 61
5.4.4 BARGAINING POWER OF BUYERS 61
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.5 REGULATORY ANALYSIS 61
5.5.1 US 61
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 62
5.5.2 EUROPE 62
5.5.3 JAPAN 63
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 63
5.6 PRICING ANALYSIS 64
TABLE 7 PRICING ANALYSIS: MICROCATHETERS MARKET, 2023 (USD) 64
5.7 REIMBURSEMENT SCENARIO ANALYSIS 65
TABLE 8 CPT CODES FOR MAJOR MICROCATHETERS 65
5.8 ECOSYSTEM MAPPING 65
5.9 VALUE CHAIN ANALYSIS 65
5.9.1 RESEARCH & DEVELOPMENT 66
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT 66
5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 66
FIGURE 25 VALUE CHAIN ANALYSIS: MICROCATHETERS MARKET 66
5.10 SUPPLY CHAIN ANALYSIS 67
5.10.1 PROMINENT COMPANIES 67
5.10.2 SMALL & MEDIUM-SIZED COMPANIES 67
5.10.3 END USERS 67
FIGURE 26 SUPPLY CHAIN ANALYSIS: MICROCATHETERS MARKET 67
5.11 PATENT ANALYSIS 67
TABLE 9 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 68
TABLE 10 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 69
5.12 TECHNOLOGY ANALYSIS 69
5.13 CASE STUDY ANALYSIS 70
TABLE 11 CASE STUDY: EMBOLIZATION FOR CHEST WALL HEMORRHAGE-DIREXION MICROCATHETER STORY 70
5.14 KEY CONFERENCES AND EVENTS IN 2023–2024 70
TABLE 12 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024 70
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 27 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 71
5.16 IMPACT OF ECONOMIC RECESSION ON MICROCATHETERS MARKET 71
6 MICROCATHETERS MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 13 MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 74
TABLE 14 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 74
TABLE 15 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 75
TABLE 16 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 75
6.2 DELIVERY MICROCATHETERS 75
6.2.1 INCREASING NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 75
TABLE 17 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 76
TABLE 18 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 76
TABLE 19 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 77
TABLE 20 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 77
6.3 ASPIRATION MICROCATHETERS 78
6.3.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL CONDITIONS TO DRIVE MARKET 78
TABLE 21 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY REGION, 2020–2028 (USD MILLION) 78
TABLE 22 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 78
TABLE 23 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 79
TABLE 24 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY END USER, 2020–2028 (USD MILLION) 79
6.4 DIAGNOSTICS MICROCATHETERS 80
6.4.1 LARGE TARGET PATIENT POPULATION FOR VASCULAR DISEASES TO DRIVE MARKET 80
TABLE 25 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 80
TABLE 26 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 81
TABLE 27 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 81
TABLE 28 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 82
6.5 STEERABLE MICROCATHETERS 82
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO DRIVE MARKET 82
TABLE 29 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 83
TABLE 30 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 83
TABLE 31 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 84
TABLE 32 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 84
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 85
7.1 INTRODUCTION 86
TABLE 33 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 86
7.2 SINGLE-LUMEN MICROCATHETERS 86
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO DRIVE MARKET 86
TABLE 34 MICROCATHETERS MARKET FOR SINGLE-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 87
7.3 DUAL AND MULTI-LUMEN MICROCATHETERS 87
7.3.1 IMPROVED SURGICAL PRECISION AND INCREASED ADOPTION IN COMPLEX VASCULAR PROCEDURES TO DRIVE MARKET 87
TABLE 35 MICROCATHETERS MARKET FOR DUAL AND MULTI-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 88
8 MICROCATHETERS MARKET, BY APPLICATION 89
8.1 INTRODUCTION 90
TABLE 36 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 90
8.2 CARDIOVASCULAR APPLICATIONS 91
8.2.1 EFFECTIVE DEVICE PLACEMENT DURING MINIMALLY INVASIVE PROCEDURES AND CRITICAL CARDIAC SURGERIES TO DRIVE MARKET 91
TABLE 37 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 91
8.3 NEUROVASCULAR APPLICATIONS 91
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 91
TABLE 38 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 92
8.4 PERIPHERAL VASCULAR APPLICATIONS 92
8.4.1 RISING NUMBER OF DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO DRIVE MARKET 92
TABLE 39 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 93
8.5 UROLOGY APPLICATIONS 93
8.5.1 INCREASING PREVALENCE OF UROLOGICAL DISORDERS AND ADVANCEMENTS IN MINIMALLY INVASIVE TECHNIQUES TO DRIVE MARKET 93
TABLE 40 MICROCATHETERS MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 94
8.6 ONCOLOGY APPLICATIONS 94
8.6.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 94
TABLE 41 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 95
8.7 OTOLARYNGOLOGY APPLICATIONS 95
8.7.1 INCREASED NEED FOR DELICATE ACCESS AND PRECISE NAVIGATION IN DIAGNOSIS TO DRIVE MARKET 95
TABLE 42 MICROCATHETERS MARKET FOR OTOLARYNGOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 96
8.8 OTHER APPLICATIONS 96
TABLE 43 MICROCATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 97
9 MICROCATHETERS MARKET, BY END USER 98
9.1 INTRODUCTION 99
TABLE 44 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 99
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 99
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO DRIVE MARKET 99
TABLE 45 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2028 (USD MILLION) 100
9.3 AMBULATORY CARE CENTERS 100
9.3.1 GROWING PATIENT SUBMISSIONS FOR DIAGNOSTIC PROCEDURES IN EMERGING ECONOMIES TO DRIVE MARKET 100
TABLE 46 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2028 (USD MILLION) 101

10 MICROCATHETERS MARKET, BY REGION 102
10.1 INTRODUCTION 103
TABLE 47 MICROCATHETERS MARKET, BY REGION, 2020–2028 (USD MILLION) 103
10.2 NORTH AMERICA 104
FIGURE 28 NORTH AMERICA: MICROCATHETERS MARKET SNAPSHOT 104
10.2.1 RECESSION IMPACT: NORTH AMERICA 105
TABLE 48 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 105
TABLE 49 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 106
TABLE 50 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 106
TABLE 51 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 107
TABLE 52 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 107
10.2.2 US 108
10.2.2.1 US to dominate North American microcatheters market during forecast period 108
TABLE 53 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 108
10.2.3 CANADA 108
10.2.3.1 Increasing prevalence of target diseases and high demand for timely diagnosis to drive market 108
TABLE 54 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 109
10.3 EUROPE 109
10.4 RECESSION IMPACT: EUROPE 109
TABLE 55 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 110
TABLE 56 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 110
TABLE 57 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 111
TABLE 58 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 111
TABLE 59 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 112
10.4.1 GERMANY 112
10.4.1.1 Increasing aging population and rising life expectancy to drive market 112
TABLE 60 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 112
10.4.2 FRANCE 113
10.4.2.1 Significant evolution of healthcare sector and growth in geriatric population to drive market 113
TABLE 61 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 113
10.4.3 UK 113
10.4.3.1 High burden of chronic diseases and large volumes of surgeries to drive market 113
TABLE 62 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 114
10.4.4 ITALY 114
10.4.4.1 Increasing geriatric population to drive market 114
TABLE 63 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 114
10.4.5 SPAIN 115
10.4.5.1 Increasing technological developments in healthcare sector to drive market 115
TABLE 64 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 115
10.4.6 REST OF EUROPE 115
TABLE 65 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 116
10.5 ASIA PACIFIC 116
10.6 RECESSION IMPACT: ASIA PACIFIC 116
FIGURE 29 ASIA PACIFIC: MICROCATHETERS MARKET SNAPSHOT 117
TABLE 66 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 118
TABLE 67 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 118
TABLE 68 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 118
TABLE 69 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 119
TABLE 70 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 119
10.6.1 JAPAN 119
10.6.1.1 Increasing geriatric population and surgical procedures to drive market 119
TABLE 71 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 120
10.6.2 CHINA 120
10.6.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to drive market 120
TABLE 72 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 121
10.6.3 INDIA 122
10.6.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market 122
TABLE 73 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 122
10.6.4 AUSTRALIA 122
10.6.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 122
TABLE 74 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 123
10.6.5 SOUTH KOREA 123
10.6.5.1 Growing target patient population to drive market 123
TABLE 75 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 123
10.6.6 REST OF ASIA PACIFIC 124
TABLE 76 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 124
10.7 LATIN AMERICA 124
10.8 RECESSION IMPACT: LATIN AMERICA 125
TABLE 77 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 125
TABLE 78 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 125
TABLE 79 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 126
TABLE 80 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 126
TABLE 81 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 127
10.8.1 BRAZIL 127
10.8.1.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 127
TABLE 82 BRAZIL: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 127
10.8.2 MEXICO 128
10.8.2.1 Favorable government initiatives and rapidly growing healthcare sector to drive market 128
TABLE 83 MEXICO: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 128
10.9 MIDDLE EAST & AFRICA 128
10.9.1 INCREASING FOCUS OF MARKET PLAYERS AND ONGOING ECONOMIC GROWTH TO DRIVE MARKET 128
10.10 RECESSION IMPACT: MIDDLE EAST & AFRICA 129
TABLE 84 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 129
TABLE 85 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 130
TABLE 86 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 130
TABLE 87 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 131

11 COMPETITIVE LANDSCAPE 132
11.1 OVERVIEW 132
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 132
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET 133
TABLE 88 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET 133
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 134
FIGURE 30 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 135
11.4 MARKET RANKING ANALYSIS 135
FIGURE 31 MICROCATHETERS MARKET RANKING, BY KEY PLAYER (2022) 136
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 138
11.5.1 STARS 138
11.5.2 EMERGING LEADERS 138
11.5.3 PERVASIVE PLAYERS 138
11.5.4 PARTICIPANTS 138
FIGURE 32 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 139
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 140
11.6.1 PROGRESSIVE COMPANIES 140
11.6.2 STARTING BLOCKS 140
11.6.3 RESPONSIVE COMPANIES 140
11.6.4 DYNAMIC COMPANIES 140
FIGURE 33 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/ SMES, 2022 141
11.7 COMPANY FOOTPRINT 142
TABLE 89 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN MICROCATHETERS MARKET 142
TABLE 90 COMPANY PRODUCT FOOTPRINT 143
TABLE 91 COMPANY GEOGRAPHICAL FOOTPRINT 144
11.8 COMPETITIVE SCENARIOS AND TRENDS 145
TABLE 92 KEY PRODUCT LAUNCHES 145
TABLE 93 KEY DEALS 146
TABLE 94 OTHER KEY DEVELOPMENTS 147
12 COMPANY PROFILES 148
12.1 KEY PLAYERS 148
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MEDTRONIC 148
TABLE 95 MEDTRONIC: COMPANY OVERVIEW 148
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2022) 149
12.1.2 BOSTON SCIENTIFIC CORPORATION 152
TABLE 96 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 152
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 153
12.1.3 TERUMO MEDICAL CORPORATION 157
TABLE 97 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 157
FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 158
12.1.4 TELEFLEX INCORPORATED 162
TABLE 98 TELEFLEX INCORPORATED: COMPANY OVERVIEW 162
FIGURE 37 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 163
12.1.5 MERIT MEDICAL SYSTEMS, INC. 167
TABLE 99 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 167
FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 168
12.1.6 ASAHI INTECC CO., LTD. 171
TABLE 100 ASAHI INTECC CO., LTD.: COMPANY OVERVIEW 171
FIGURE 39 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2022) 172
12.1.7 STRYKER 175
TABLE 101 STRYKER: COMPANY OVERVIEW 175
FIGURE 40 STRYKER: COMPANY SNAPSHOT (2022) 176
12.1.8 SURMODICS, INC. 178
TABLE 102 SURMODICS, INC.: COMPANY OVERVIEW 178
FIGURE 41 SURMODICS, INC.: COMPANY SNAPSHOT (2022) 179
12.1.9 CARDINAL HEALTH, INC. 181
TABLE 103 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 181
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022) 182
12.1.10 JOHNSON & JOHNSON 184
TABLE 104 JOHNSON & JOHNSON: COMPANY OVERVIEW 184
FIGURE 43 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 185
12.1.11 GUERBET LLC 188
TABLE 105 GUERBET LLC: COMPANY OVERVIEW 188
FIGURE 44 GUERBET LLC: COMPANY SNAPSHOT (2022) 189
12.1.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD 191
TABLE 106 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 191
FIGURE 45 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT (2022) 192
12.1.13 BECTON, DICKINSON AND COMPANY 194
TABLE 107 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 194
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 195
12.1.14 PENUMBRA, INC. 197
TABLE 108 PENUMBRA, INC.: COMPANY OVERVIEW 197
FIGURE 47 PENUMBRA, INC.: COMPANY SNAPSHOT (2022) 198
12.1.15 KANEKA CORPORATION 200
TABLE 109 KANEKA CORPORATION: COMPANY OVERVIEW 200
FIGURE 48 KANEKA CORPORATION: COMPANY SNAPSHOT (2022) 201
12.1.16 ANGIODYNAMICS, INC. 203
TABLE 110 ANGIODYNAMICS, INC.: COMPANY OVERVIEW 203
FIGURE 49 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022) 204
12.1.17 BIOCARDIA INC. 206
TABLE 111 BIOCARDIA INC.: COMPANY OVERVIEW 206
12.2 OTHER PLAYERS 208
12.2.1 MILLAR, INC. 208
12.2.2 BAYLIS MEDICAL COMPANY, INC. 209
12.2.3 EMBOLX, INC. 210
12.2.4 ACANDIS GMBH 211
12.2.5 ACROSTAK 212
12.2.6 COOK MEDICAL 213
12.2.7 REFLOW MEDICAL, INC. 214
12.2.8 TZ MEDICAL, INC. 215
12.2.9 ORBUSNEICH MEDICAL 216
12.2.10 SPARTAN MICRO, INC. 217
12.2.11 TRANSIT SCIENTIFIC 218
12.2.12 TOKAI MEDICAL PRODUCTS 219
12.2.13 LIBATAPE PHARMACEUTICAL CO., LTD 220
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 221
13.1 DISCUSSION GUIDE 221
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
13.3 CUSTOMIZATION OPTIONS 229
13.4 RELATED REPORTS 229
13.5 AUTHOR DETAILS 230